295 related articles for article (PubMed ID: 23482315)
21. Insights into the functionality of pelletization aid in pelletization by extrusion-spheronization.
Sarkar S; Heng PW; Liew CV
Pharm Dev Technol; 2013 Feb; 18(1):61-72. PubMed ID: 21981607
[TBL] [Abstract][Full Text] [Related]
22. Differences in characteristics of pellets prepared by different pelletization methods.
Häring A; Vetchý D; Janovská L; Krejcová K; Rabisková M
Drug Dev Ind Pharm; 2008 Mar; 34(3):289-96. PubMed ID: 18363144
[TBL] [Abstract][Full Text] [Related]
23. Analysis of particle kinematics in spheronization via particle image velocimetry.
Koester M; Thommes M
Eur J Pharm Biopharm; 2013 Feb; 83(2):307-14. PubMed ID: 23000404
[TBL] [Abstract][Full Text] [Related]
24. Production and characterization of pellets using Avicel CL611 as spheronization aid.
Puah SY; Yap HN; Chaw CS
Drug Dev Ind Pharm; 2014 Mar; 40(3):418-24. PubMed ID: 23480532
[TBL] [Abstract][Full Text] [Related]
25. Approaches to developing fast release pellets via wet extrusion-spheronization.
Xia Y; Shi CY; Fang JG; Wang WQ
Pharm Dev Technol; 2018 Jun; 23(5):432-441. PubMed ID: 27882815
[TBL] [Abstract][Full Text] [Related]
26. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler.
Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2006 May; 63(1):59-67. PubMed ID: 16326085
[TBL] [Abstract][Full Text] [Related]
27. Losartan potassium sustained release pellets with improved
Abou Obaid NI; Al-Jenoobi FI; Ibrahim MA; Alam MA
Pharm Dev Technol; 2020 Nov; 25(9):1031-1042. PubMed ID: 32538215
[TBL] [Abstract][Full Text] [Related]
28. Alternative extrusion-spheronization aids.
Jain SP; Singh PP; Amin PD
Drug Dev Ind Pharm; 2010 Nov; 36(11):1364-76. PubMed ID: 20521907
[TBL] [Abstract][Full Text] [Related]
29. A Quality by Experimental Design Approach to Assess the Effect of Formulation and Process Variables on the Extrusion and Spheronization of Drug-Loaded Pellets Containing Polyplasdone® XL-10.
Saripella KK; Loka NC; Mallipeddi R; Rane AM; Neau SH
AAPS PharmSciTech; 2016 Apr; 17(2):368-79. PubMed ID: 26169900
[TBL] [Abstract][Full Text] [Related]
30. Use of extrusion aids for successful production of Kollidon
Loka NC; Saripella KK; Pinto CA; Neau SH
Drug Dev Ind Pharm; 2018 Apr; 44(4):632-642. PubMed ID: 29183166
[TBL] [Abstract][Full Text] [Related]
31. Direct pelletization in a rotary processor controlled by torque measurements. III. Investigation of microcrystalline cellulose and lactose grade.
Kristensen J
AAPS PharmSciTech; 2005 Oct; 6(3):E495-503. PubMed ID: 16354010
[TBL] [Abstract][Full Text] [Related]
32. A protocol for the classification of wet mass in extrusion-spheronization.
Gao Y; Hong Y; Xian J; Lin X; Shen L; Zhang X; Zhang N; Feng Y
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):996-1005. PubMed ID: 23563104
[TBL] [Abstract][Full Text] [Related]
33. Predicting optimal wet granulation parameters for extrusion-spheronisation of pharmaceutical pellets using a mixer torque rheometer.
Kuhs M; Moore J; Kollamaram G; Walker G; Croker D
Int J Pharm; 2017 Jan; 517(1-2):19-24. PubMed ID: 27915006
[TBL] [Abstract][Full Text] [Related]
34. EVALUATION OF DICLOFENAC SODIUM SUSTAINED RELEASE MATRIX PELLETS: IMPACT OF POLYETHYLENE GLYCOLS MOLECULAR WEIGHT.
Ibrahim MA; Shazly GA
Acta Pol Pharm; 2015; 72(5):987-97. PubMed ID: 26665407
[TBL] [Abstract][Full Text] [Related]
35. The use of partially hydrolysed polyvinyl alcohol for the production of high drug-loaded sustained release pellets via extrusion-spheronisation and coating: In vitro and in vivo evaluation.
Verstraete G; De Jaeghere W; Vercruysse J; Grymonpré W; Vanhoorne V; Stauffer F; De Beer T; Bezuijen A; Remon JP; Vervaet C
Int J Pharm; 2017 Jan; 517(1-2):88-95. PubMed ID: 27919698
[TBL] [Abstract][Full Text] [Related]
36. New co-processed MCC-based excipient for fast release of low solubility drugs from pellets prepared by extrusion-spheronization.
Goyanes A; Martínez-Pacheco R
Drug Dev Ind Pharm; 2015 Mar; 41(3):362-8. PubMed ID: 24279425
[TBL] [Abstract][Full Text] [Related]
37. Combined effects of wetting, drying, and microcrystalline cellulose type on the mechanical strength and disintegration of pellets.
Balaxi M; Nikolakakis I; Kachrimanis K; Malamataris S
J Pharm Sci; 2009 Feb; 98(2):676-89. PubMed ID: 18548618
[TBL] [Abstract][Full Text] [Related]
38. Influence of formulation and excipient variables on the pellet properties prepared by extrusion spheronization.
Sinha VR; Agrawal MK; Kumria R
Curr Drug Deliv; 2005 Jan; 2(1):1-8. PubMed ID: 16305403
[TBL] [Abstract][Full Text] [Related]
39. A method for the preparation of sustained release-coated Metoprolol Succinate pellet-containing tablets.
Yang Z; Yu J; Yang T; Xing H; Zhang J; Xian L; Ding P; Wang D
Pharm Dev Technol; 2016 Dec; 21(8):943-950. PubMed ID: 26334840
[TBL] [Abstract][Full Text] [Related]
40. Sustained-release pellets of nifedipine using microcrystals combined with MCC-based matrix.
Ma J; Wang J; Cheng Z; Yin T; Teng H; Xu H; Tang X; Cai C
Drug Dev Ind Pharm; 2015 Feb; 41(2):307-14. PubMed ID: 24320880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
